Εlias Iosifidis
- Molecular Medicine top 0.5%
- Antibiotic Resistance in Bacteria 33
-
- Antibiotic Use and Resistance 15
- Endocrinology top 2%
- Clinical Biochemistry top 2%
- Bacterial Identification and Susceptibility Testing 11
-
- Nosocomial Infections in ICU 15
-
- Antibiotics Pharmacokinetics and Efficacy 26
-
- Pneumonia and Respiratory Infections 17
-
- Antifungal resistance and susceptibility 15
- Antimicrobial Resistance in Staphylococcus 11
- Co-authors
- Emmanuel RoilidesCharalampos AntachopoulosDanai SofianouTheodoros KarampatakisJohn DotisN. Gritsi-GerogianniEleni MouloudiAthanasios Tsakris
- Journals
- The Pediatric Infectious Disease Journal (12 papers)Infection Control and Hospital Epidemiology (6 papers)Antibiotics (4 papers)
- Partner nations
- GreeceUnited StatesUnited Kingdom
In The Last Decade
Εlias Iosifidis
79 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 89
- Molecular Medicine 792
- Applied Microbiology and Biotechnology 302
- Endocrinology 182
- Clinical Biochemistry 188
- Critical Care and Intensive Care Medicine 142
Countries citing papers authored by Εlias Iosifidis
This map shows the geographic impact of Εlias Iosifidis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Εlias Iosifidis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Εlias Iosifidis more than expected).
Fields of papers citing papers by Εlias Iosifidis
This network shows the impact of papers produced by Εlias Iosifidis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Εlias Iosifidis. The network helps show where Εlias Iosifidis may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Εlias Iosifidis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 1 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 4 | |
| 6 | 2023 | 4 | |
| 7 | 2023 | 3 | |
| 8 | 2023 | 2 | |
| 9 | 2023 | 9 | |
| 10 | 2022 | 4 | |
| 11 | 2021 | 12 | |
| 12 | 2020 | 4 | |
| 13 | 2020 | 7 | |
| 14 | 2019 | 2 | |
| 15 | 2019 | 9 | |
| 16 | 2019 | 9 | |
| 17 | 2019 | 10 | |
| 18 | 2018 | 14 | |
| 19 | 2018 | 50 | |
| 20 | 2015 | 13 |
About Εlias Iosifidis
Εlias Iosifidis is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine and Critical Care and Intensive Care Medicine, having authored 82 papers that have together received 1.5k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (33 papers), Antibiotics Pharmacokinetics and Efficacy (26 papers), Pneumonia and Respiratory Infections (17 papers), Antifungal resistance and susceptibility (15 papers), Antibiotic Use and Resistance (15 papers), Nosocomial Infections in ICU (15 papers), Antimicrobial Resistance in Staphylococcus (11 papers) and Bacterial Identification and Susceptibility Testing (11 papers). The work is most often cited by research in Molecular Medicine (792 citations), Applied Microbiology and Biotechnology (302 citations) and Endocrinology (182 citations). Εlias Iosifidis has collaborated with scholars based in Greece, United States and United Kingdom. Frequent co-authors include Emmanuel Roilides, Charalampos Antachopoulos, Danai Sofianou, Theodoros Karampatakis, John Dotis, N. Gritsi-Gerogianni, Eleni Mouloudi, Athanasios Tsakris, Efthymia Protonotariou and Μαρία Σδούγκα. Their work appears in journals such as The Pediatric Infectious Disease Journal, Infection Control and Hospital Epidemiology, Antibiotics, Journal of Fungi and American Journal of Infection Control.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.